References
- Mameniskiene R., Bast T., Bentes C., Canevini M.P., Dimova P., Granata T. et al.:Clinical course and variability of nonRasmussen, nonstroke motor and sensory epilepsia partialis continua: A European survey and analysis of 65 cases. Epilepsia, 2011, 52: 1168–1176.
- Rajasekaran K., Joshi S., Kozhemyakin M., Todorovic M.S., Kowalsky S., Balint C., Kapur J.:
Receptor trafficking hypothesis revisited: Plasticity of AMPA receptors during established status epilepticus . Epilepsia, 2013, 54 (Suppl. 6): 14–16. - Redecker J., Wittstock M., Benecke R., Rösche J.:Efficacy of perampanel in refractory nonconvulsive status epilepticus and simple partial status epilepticus. Epilepsy and Behavior, 2015, 45: 176–179.
- Rohracher A., Höfler J., Kalss G., Leitinger M., Kuchukhidze G., Deak I. et al.:Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit. Epilepsy and Behavior, 2015, 49: 354–358.
- Rösche J., Kampf C., Benecke R.:
Possible effect of perampanel on focal status epilepticus after generalized tonic-clonic status epilepticus . Acta Neurologica Belgica, 2014, 114: 243–244. - Rösche J., Redecker J.:Treatment of status epilepticus – A narrative review on the evidence so far and a proposal for the design of retrospective studies. Eur. Med. Journ. Neurol., 2015, 3: 91–95.
- Shorvon S., Baulac M., Cross H., Trinka E., Walker M.:
The drug treatment of status epilepticus in Europe: Consensus document from a workshop at the first London Colloquium on Status Epilepticus . Epilepsia, 2008, 49: 1277–1284. - Steinhoff B.J.:Das neue Antiepileptikum Perampanel. Psycho-pharmakotherapie, 2012, 19: 202–208.
- Trinka E., Hesdorfer D., Rossetti A.O., Scheffer I.E., Shin-nar S. et al.:A definition and classification of status epilepticus – Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia, 2015a, 56: 1515–1523.
- Trinka E., Steinhoff B.J., Nikanorova M, Brodie M.J.:Peram-panel for focal epilepsy: insights from early clinical experience. Acta Neurol. Scand., 2015b, DOI:10.1111/ane.12529
- Varadkar S., Bien C.G., Kruse C.A., Jensen F.E., Bauer J., Pardo C.A. et al.:Rasmussen’s encephalitis: clinical features, patho-biology and treatment advances. Lancet Neurology, 2014, 13: 195–205.
- Watson R., Jiang Y., Bermudez I., Houlihan L., Clover L., McKnight K. et al.:Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis. Neurology, 2004, 63: 43–50.